Sort by
Refine Your Search
-
Program
-
Employer
- Universitat de Barcelona
- Centre de Recerca en Agrigenòmica
- ICN2
- Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)
- BarcelonaBeta Brain Research Center
- Biodiversity Research Institut-University of Barcelona (IRBio-UB)
- CRAG-Centre de Recerca Agrigenòmica
- IDIBELL
- Institut Català de Nanociència i Nanotecnologia
- Josep Carreras Leukaemia Research Institute (IJC)
-
Field
-
the Regenbell Program at IDIBELL and the Department of Physiological Science at University of Barcelona-Campus Bellvitge. Our team is dedicated to various projects centered around pancreas biology, pancreas
-
methods and setups for the investigation of novel electrocatalysts and electrocatalytic reactions. The research will be carried out in close collaboration with a theoretical group at the University
-
methods and setups for the investigation of novel electrocatalysts and electrocatalytic reactions. The research will be carried out in close collaboration with a theoretical group at the University
-
the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine
-
of the Pompeu Fabra University of Barcelona. This building provides excellent technical facilities, such as a 3TMR scanner dedicated to research, Clinical Trials facilities, EEG and a wet laboratory. The BBRC's
-
developed together with Agbio, Biotech, and Breeding companies. CRAG is located at the campus of the Autonomous University of Barcelona (UAB), and currently hosts over 200 members from across the world
-
renewable) post-doctoral position in time-domain astronomy at the Institute of Cosmos Sciences at the University of Barcelona (ICCUB), Spain. The postdoctoral researcher will join the research group led by
-
methods and setups for the investigation of novel electrocatalysts and electrocatalytic reactions. The research will be carried out in close collaboration with a theoretical group at the University
-
Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer